European Commission

News

EU clears path for Pfizer’s takeover of Seagen

Pfizer’s $43 billion acquisition of antibody-drug conjugate specialist Seagen has been given the go-ahead by the authorities in the EU, clearing a key remaining obstacle t

Sales & Marketing

EU pharmaceutical reform: Balancing access, innovation, and ...

After much anticipation, some leaks, and several delays, the European Commission has unveiled its latest proposal for a new regulation and directive to replace the existing provisions on me

News

Pharma incensed by EU's compulsory licensing proposal

Pharma industry bodies have slammed a proposal by the European Commission to set up a compulsory licensing (CL) framework for medicines in emergency situations, claiming t

News

EU sets up €100m fund to tackle health threats

The EU has set aside a €100 million block of financing for small- and medium-sized enterprises working on projects that could tackle public health threats, including emerg

News

Single market at heart of EU plans for pharma reform

The European Commission’s long-promised revamp of pharmaceutical legislation is finally unveiled, and it’s ambitious to say the least.

News

Rare Disease Moonshot launched at European Health Summit

A new initiative to boost research and development into rare and paediatric diseases launched last week, on Thursday 8th December, at the European Health Summit.

EU clears path for Pfizer’s takeover of Seagen

EU pharmaceutical reform: Balancing access, innovation, and ...

Pharma incensed by EU's compulsory licensing proposal

EU sets up €100m fund to tackle health threats

Single market at heart of EU plans for pharma reform

Rare Disease Moonshot launched at European Health Summit

OpenBind unveils its first AI model for drug discovery

Discover a new era of healthcare panel engagement: Grounded ...

European Commission

Editor's Picks